Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

The user is updating on their 3-month progress using minoxidil (0.5mg twice daily) and microneedling once a week. They plan to consult a doctor about adding finasteride to their regimen.

The user shared a two-year update on hair loss treatment using oral minoxidil, finasteride, and microneedling, noting significant progress after starting oral treatments and microneedling. They began treatment in early 2023 after noticing hair loss in late 2021.

The user experienced significant hair regrowth after 4.5 months using 1.25 mg finasteride and 3% minoxidil daily, with no side effects. Others shared their experiences, with some considering adjusting doses or switching treatments due to varying results.

The conversation is about hair loss treatments, specifically the use of 1 mg finasteride and 1.5 mg oral minoxidil over two years, with consideration of a future hair transplant and possibly switching to dutasteride. Users discuss their own experiences and suggest trying different treatments like minoxidil 5%.

The user is experiencing hair regrowth using 1.2 mg oral finasteride and 3 mg oral minoxidil after aggressive balding. They express concerns about hair loss affecting confidence and consider additional treatments like dutasteride.

The user shared progress pictures after using 2.5 mg Minoxidil and 1 mg Finasteride for three months, noting improved hair appearance. Others suggested adding Nizoral and taking more consistent photos over time.

The conversation discusses the comparison of Pyrilutamide Phase II US trial results with 1 mg finasteride for hair loss treatment. It mentions that the total hair count increase in the US trial was not as good as the China trial.

MCL-1 protein may help maintain hair follicles in the growth phase and prevent miniaturization. There is interest in experimental treatments like exosomes, peptides, or stem cell serums to upregulate MCL-1 for hair loss, especially for those not using minoxidil or finasteride.

The conversation discusses the effectiveness and potential side effects of using a minoxidil, finasteride, and biotin combination pill for hair loss, comparing half-dose (0.55mg Fin, 2.5mg Min, 0.5mg Biotin) to full-dose (1.1mg Fin, 5mg Min, 1mg Biotin). The user is considering whether to increase to a full dose after starting with a half dose.

Painkillers like Aspirin may reduce Minoxidil's effectiveness by inhibiting the enzyme PGHS-1, which is crucial for hair growth. Using NSAIDs that inhibit COX-2 or combining Minoxidil with PGF2/E2 analogues or retinoids may enhance its efficacy.

The user is experiencing new hair growth at the temples after 2 months of using 1mg finasteride and 3mg minoxidil. Others are optimistic about the progress and encourage patience.

The user reported using 1.2 mg finasteride and 3 mg minoxidil, experiencing initial shedding and increased hair growth on knuckles, arms, and forehead. They did not notice any significant side effects.

The user improved their hair with 0.5mg dutasteride, 2.5mg oral minoxidil, and a hair transplant of 2500 grafts in the frontal area over two years. They reported no significant side effects from the medication, except for reduced sexual function.

A user applied the 8T3 product for hair loss, targeting LPP and AGA, and plans to update on its effectiveness. The product uses a saline buffered phosphate vehicle, suitable for those intolerant to ethanolic vehicles.

The user has made significant hair growth progress in 3 months using 1mg oral finasteride and 5% topical minoxidil twice daily, with plans to start 1.25mg oral minoxidil. The user is considering a hair transplant in 1-2 years and is cautious about using a dermastamp to avoid scar tissue.

The conversation discusses using Minoxidil, finasteride, RU58841, and pyrilutamide for hair loss treatment. The user is considering adding a topical treatment and has not experienced side effects from current treatments.

The conversation discusses hair loss treatments, mentioning minoxidil, finasteride, RU58841, VDPHL, GT20029, and follicle cloning as potential solutions. It also reveals that the discussion about PP405 was an April Fool's joke.

The user is taking a 2-in-1 pill containing 1mg finasteride and 3mg minoxidil daily, noticing some hair thickening and new hair growth but minimal progress at the back of the head. They are considering adding topical minoxidil or increasing dosage and are unsure if they should change their routine or wait for more results.

The user shared progress pictures showing improved hair density after using topical Minoxidil for two years and topical Finasteride for one year, with occasional microneedling. They adjusted Finasteride concentration over time and are considering additional treatments like a hair transplant.

The user has been using minoxidil, finasteride, and microneedling for two years, resulting in significant hair regrowth and plans for a 4000 graft hair transplant. The treatments have strengthened the donor area, making a hair transplant feasible.

The user started taking 1 mg of Finasteride and 3 mg of Minoxidil orally to address hair loss. They are seeking advice on the effectiveness and appropriate dosage of these treatments.

PP405 increased hair density by 20% in 31% of participants, but results are considered underwhelming. Minoxidil and finasteride are seen as more effective treatments.

The user claims significant hair regrowth using 2.5mg Minoxidil and 1mg Finasteride over three months, but others question the validity due to differences in hair styling between photos. The user reports no side effects except for body hair growth.

A new hair loss treatment, PP405, is moving from phase 2A to 2B in clinical trials, sparking discussions about its potential to regrow dormant hairs and its impact on existing treatments like Minoxidil and finasteride. Some users express skepticism, while others are hopeful about its future effectiveness.

Kintor's phase III trial for pyri (KX-826) showed promising safety and efficacy results, with no drug-related sexual dysfunction reported. Users discussed their experiences with pyri, Minoxidil, Dutasteride, and concerns about the validity of the study results.

A 26-year-old experienced significant hairline regrowth in 4 months using 1 mg finasteride and 3 mg oral minoxidil, with additional weekly derma stamping. Minoxidil was credited for the regrowth, with noticeable results appearing 3-4 weeks after starting the treatment.

The user shared progress on hair regrowth using 1mg finasteride and 2.25mg oral minoxidil daily, noticing thicker hair and new growth after initial shedding. Others encouraged patience, noting that significant results often appear after several months.

The conversation discusses hair loss treatments, specifically using Minoxidil, microneedling, and finasteride. The user is concerned about worsening hair loss and is advised to consider finasteride.

The phase 3 trial results for Pyrilutamide showed no significant difference from the control treatment in increasing hair count, leading to the company halting its development. Users discussed their disappointment and skepticism about hair loss treatments, with some mentioning other treatments like Minoxidil, Finasteride, and RU58841.

User shared progress pictures showing significant hair regrowth using a compounded solution of Minoxidil 10%, Finasteride 0.1%, Biotin 0.2%, and Latanoprost 0.005%. They reported no side effects and are satisfied with the results.